PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
401,500
-9,500 (-2.31%)
At close: Dec 5, 2025
85.02%
Market Cap 4.17T
Revenue (ttm) 496.03B
Net Income (ttm) 151.24B
Shares Out 10.39M
EPS (ttm) 14,523.95
PE Ratio 27.64
Forward PE 18.76
Dividend 1,100.00 (0.27%)
Ex-Dividend Date Dec 29, 2025
Volume 104,024
Average Volume 197,517
Open 407,500
Previous Close 411,000
Day's Range 398,500 - 412,000
52-Week Range 201,500 - 713,000
Beta 0.54
RSI 38.14
Earnings Date Nov 11, 2025

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 450
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.

Financial Statements

News

There is no news available yet.